Thermo Fisher Scientific Inc. (TN8.DE)
EUR 373.5
(-0.63%)
EUR 373.5
(-0.63%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 22.83 Billion USD | -9.86% |
| 2022 | 9.79 Billion USD | 19.54% |
| 2021 | 8.19 Billion USD | 23.35% |
| 2020 | 6.64 Billion USD | 5.27% |
| 2019 | 6.31 Billion EUR | 1.4% |
| 2018 | 6.22 Billion EUR | 16.58% |
| 2017 | 5.33 Billion EUR | -1.59% |
| 2016 | 5.42 Billion EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 2.31 Billion USD | -5.49% |
| 2024 Q2 | 2.45 Billion EUR | 3.56% |
| 2023 FY | 8.83 Billion USD | -9.86% |
| 2023 Q4 | 1.77 Billion USD | -20.31% |
| 2023 Q3 | 2.23 Billion USD | -2.21% |
| 2023 Q2 | 2.28 Billion USD | -0.31% |
| 2023 Q1 | 2.28 Billion USD | 12.75% |
| 2022 Q1 | 2.38 Billion EUR | 20.56% |
| 2022 FY | 9.79 Billion USD | 19.54% |
| 2022 Q4 | 2.02 Billion USD | -22.43% |
| 2022 Q3 | 2.61 Billion EUR | 3.66% |
| 2022 Q2 | 2.52 Billion EUR | 5.71% |
| 2021 Q4 | 1.98 Billion EUR | 0.0% |
| 2021 FY | 8.19 Billion USD | 23.35% |
| 2020 FY | 6.64 Billion USD | 5.27% |
| 2019 FY | 6.31 Billion EUR | 1.4% |
| 2018 FY | 6.22 Billion EUR | 16.58% |
| 2017 FY | 5.33 Billion EUR | -1.59% |
| 2016 FY | 5.42 Billion EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| NanoRepro AG | 7.17 Million EUR | -318299.206% |